Quantum Biopharma has bought a further $1 million price of Bitcoin and different cryptocurrencies, the Canadian biotechnology firm stated.
The buys take Quantum’s whole cryptocurrency holdings to roughly $4.5 million, according to a Could 19 press launch. The biotech firm plans to stake a portion of its crypto to generate income.
Quantum expects that holding a treasury of Bitcoin (BTC) and different crypto property will “present a return on funding for shareholders and […] present some hedge towards the Canadian greenback,” it said.
Shares of Quantum’s inventory, QNTM, rose by roughly 25% following the announcement, in response to data from Google Finance.
Associated: Basel Medical shares down 15% on $1B Bitcoin buying plans
In style treasury technique
Quantum is certainly one of a number of healthcare firms accumulating Bitcoin as company crypto treasuries develop into more and more fashionable.
In March, NASDAQ-listed biopharmaceutical firm Atai Life Sciences tipped plans to buy $5 million worth of Bitcoin.
In a March 20 X post, Atai’s founder, Christian Angermayer, stated “Bitcoin must be part of ANY company treasury – particularly, in actual fact, within the biotech sector.”
Angermayer added in a weblog post that Bitcoin might help the biotech hedge towards inflation and keep solvent in the course of the lengthy durations earlier than drug approvals.
On Could 16, Singapore-based healthcare firm Basel Medical Group introduced plans to buy $1 billion worth of Bitcoin.
It stated a Bitcoin treasury will assist its plans to develop in Asia by means of acquisitions by giving Basel “one of many strongest stability sheets amongst Asia-focused healthcare suppliers.”
In contrast to Quantum, nevertheless, Basel’s shares dropped considerably on the day of the announcement.
Collectively, company treasuries maintain greater than $83 billion in Bitcoin as of Could 19, according to knowledge from BitcoinTreasuries.NET.
Publicly traded firms at the moment are the biggest institutional Bitcoin holders after exchange-traded funds (ETFs), the info exhibits.
Bitcoin can “doubtlessly be a beneficial hedge towards rising fiscal deficits, foreign money debasement, and geopolitical dangers” for firms, asset supervisor Constancy Digital Belongings said in a 2024 report.
Journal: Danger signs for Bitcoin as retail abandons it to institutions: Sky Wee
